Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Heart Test Laboratories Q2 EPS $(2.27) Beats $(2.43) Estimate

Author: Benzinga Newsdesk | December 16, 2024 04:25pm
Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(2.27) per share which beat the analyst consensus estimate of $(2.43) by 6.58 percent. This is a 85.74 percent increase over losses of $(15.92) per share from the same period last year.

Posted In: HSCS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist